6th Dec 2007 17:48
Ark Therapeutics Group PLC06 December 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached: ARK THERAPEUTICS GROUP PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( X ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation: GAM International Management Limited 4. Full name of shareholder(s) (if different from 3.): 5. Date of the transaction and date on which the threshold is crossed or reachedif different): 30 November 2007 6. Date on which issuer notified: 6 December 2007 7. Threshold(s) that is/are crossed or reached: 3% and 4% 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous to if possible using the the Triggering ISIN CODE transaction Number of shares Number of voting Rights Ordinary shares 2,735,454 2,735,454 Resulting situation after the triggering transaction Class/type of shares Number of shares Number of voting rights % of voting rights if possible using the ISIN CODE Direct Direct Indirect Direct Indirect Ordinary shares 8,292,168 8,292,168 4.11% B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Date Exercise/Conversion Number of voting % of voting financial Period/ Date rights that may be rights instrument acquired if the instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 8,292,168 4.11% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: GAM International Management Limited is the discretionary investment manager for the following: Period of interest 24 November 2007 - 4 December 2007 Trade Date Fund Name Nominal Running % of Total issue 24.11.07 Opening balance 2,252,728 2,252,728 1.1228.11.07 GAM Exempt Trust - UK Opportunities 128,050 2,380,778 1.1828.11.07 GAM UK Diversified 354,676 2,735,454 1.35 30.11.07 GAM Exempt Trust - UK Opportunities 606,584 3,342,038 1.6530.11.07 GAM UK Diversified 1,610,530 4,952,568 2.4530.11.07 SJP GAM Managed - Life 1,862,300 6,814,868 3.3730.11.07 SJP GAM Managed - Pension 1,477,300 8,292,168 4.11 Proxy Voting: 10. Name of the proxy holder: Institutional Shareholder Services 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14. Contact name: Kemi Thomas 15. Contact telephone number: 020 7917 2346 16. Contact name and telephone at issuer: NICK PLUMMERCompany SecretaryArk Therapeutics Group plc 020 7388 7722 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
PVG.L